|Year : 2020 | Volume
| Issue : 4 | Page : 89-90
Repositioning the Journal of Clinical Sciences for greater impact: Stepping out of the “comfort zone”
Adesoji O Ademuyiwa
Editor in Chief
|Date of Web Publication||19-Oct-2020|
Prof. Adesoji O Ademuyiwa
Editor in Chief
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Ademuyiwa AO. Repositioning the Journal of Clinical Sciences for greater impact: Stepping out of the “comfort zone”. J Clin Sci 2020;17:89-90
“All progress takes place outside the comfort zone.”
– Michael John Bobak.
The Journal of Clinical Sciences is gradually stepping out of its comfort zone.
With about 2 decades in the saddle and 17 volumes gone with over 35 individual issues; and since becoming accessible online 6 years ago, over 560 authors have registered with the journal's manuscript submission system with about half that number of highly qualified and dedicated reviewers helping with the peer review process. Majority of these numbers have come from Nigeria and from the host institution of the journal – the College of Medicine of the University of Lagos – our comfort zone.
While the journal was in its comfort zone, it recorded some commendable achievements. This included, but not limited to, the migration from the physical submission of hardcopies of manuscripts or through emails to an automated manuscript submission system of an internationally respected publishing outfit - Medknow- Wolter Kluwers who has over 450 journals in their stable.. Since then, abstracts of our articles have become accessible and available from different abstracting platforms such as CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Google Scholar, Hinari, National Science Library, and Netherlands ISSN Center to mention a few. In addition, the journal is indexed with the Directorate of Open Access Journals which separates the wheat of genuine and authentic open access journals from the chaff of predatory journal open access model. Furthermore, since publishing online in 2014, the JCS has not missed any issue in spite of hard economic realities of our nation and the recent pervasive pan-socioeconomic effects of the COVID-19 pandemic. While these modest accomplishments are good, we realize that the greatest enemy of the best is the good, hence the need to step out of our comfort zone albeit gradually.
As a first step therefore, the editorial board has been expanded. To maintain the footprints of the journal's institutional affiliation, new SubEditors in the different specialties of the scope of the journal have been appointed from among members of the University. However, a bold step has been taken to “leave” the comfort zone by having international editors from the six continents of the globe and across ten countries. These are accomplished academics who stand tall in their chosen fields and who have agreed to join the boat of the JCS to ensure it gets to harbor. I am excited to welcome this pomposity of Professors on to the editorial board of JCS. Thank you for acceding to our request.
This issue of the journal promises to be very interesting from start to finish – first, we have an invited editorial from one of the Deputy Editors-in-Chief – Dr. Olukemi Odukoya, an Associate Professor of Community Medicine, who was at the frontline of the fight against COVID-19. She and her colleague share lessons learned from the fight against the disease using a state in Nigeria as an example.
Gaude and Vishwanath from Kamataka, India, reviewed the use of cutting-edge technology and genetics in the accurate diagnosis of tuberculosis infection. They surmised: “……. molecular tests have better performance characteristics in terms of increased sensitivity and better accuracy for early diagnosis of MTB as well as for detecting MDR and extensively drugresistant TB and thus represent better diagnostic tools for the rapid detection of resistance to firstline as well as secondline drugs.” Olopade et al. looked at the glycemic responses to local beans within a small population. While their study has a strong limitation of having a small sample size, the findings can be used a basis for larger studies with more generalizable information. There are many other articles that will stimulate the interest of our readers as well as interesting case reports that complete the menu. Happy reading.
| References|| |
Odukoya OO, Omeje UA. COVID-19 pandemic in Nigeria: A case study of Kano State – Challenges and lessons learned. J Clin Sci 2020;17:91-2. [Full text]
Gaude GS, Vishwanath S. Molecular diagnosis of tuberculosis with emphasis on Xpert Mycobacterium tuberculosis
assay – Clinical review. J Clin Sci 2020;17:93-9. [Full text]
Olopade OB, Odeniyi IA, Fasanmade OA, Olopade BO, Kayode OO, Anyanwu AC, et al
Glycemic responses of local beans (Vigna unguiculata
[Linn Walp] varieties) in persons with Type 2 diabetes mellitus and healthy controls. J Clin Sci 2020;17;100-7.